STRYKER CORP (SYK) Share buybacks
- Total buybacks · last 12 months (USD): Value $0.00; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2021-12-31..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2021-12-31..
Share buybacks
Overview →Financial period ending 2021-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $0.00 | Trailing-year cash paid for share repurchases. Period ending 2021-12-31. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2021-12-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 0.00 USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2021-12-31 | $0.00 | (m) | (m) |
| 2021-06-30 | $0.00 | (m) | (m) |
| 2021-03-31 | $0.00 | (m) | (m) |
| 2020-12-31 | $0.00 | (m) | (m) |
| 2020-09-30 | $0.00 | (m) | (m) |
| 2020-06-30 | $0.00 | (m) | (m) |
| 2020-03-31 | $0.00 | (m) | (m) |
| 2019-12-31 | $307.00M | (m) | (m) |
| 2019-09-30 | $307.00M | (m) | (m) |
| 2019-06-30 | $307.00M | (m) | (m) |
| 2019-03-31 | $307.00M | (m) | (m) |
| 2018-12-31 | $300.00M | (m) | (m) |
| 2018-09-30 | $300.00M | (m) | (m) |
| 2018-06-30 | $300.00M | (m) | (m) |
| 2018-03-31 | $300.00M | (m) | (m) |
| 2017-12-31 | $230.00M | (m) | (m) |
| 2017-09-30 | $230.00M | (m) | (m) |
| 2017-06-30 | $230.00M | (m) | (m) |
| 2017-03-31 | $230.00M | (m) | (m) |
| 2017-01-31 | (m) | (m) | (m) |
| 2016-12-31 | $13.00M | (m) | (m) |
| 2016-09-30 | $267.00M | (m) | (m) |
| 2016-06-30 | $389.00M | (m) | (m) |
| 2016-03-31 | $583.00M | (m) | (m) |
| 2015-12-31 | $700.00M | (m) | (m) |
| 2015-09-30 | $446.00M | (m) | (m) |
| 2015-06-30 | $364.00M | (m) | (m) |
| 2015-03-31 | $230.00M | (m) | (m) |
| 2014-12-31 | $100.00M | (m) | (m) |
| 2014-09-30 | $165.00M | (m) | (m) |
| 2014-06-30 | $127.00M | (m) | (m) |
| 2014-03-31 | $67.00M | (m) | (m) |
| 2013-12-31 | $317.00M | (m) | (m) |
| 2013-09-30 | $252.00M | (m) | (m) |
| 2013-06-30 | $269.00M | (m) | (m) |
| 2013-03-31 | $308.00M | (m) | (m) |
| 2012-12-31 | $108.00M | (m) | (m) |
| 2012-09-30 | $191.00M | (m) | (m) |
| 2012-06-30 | $461.00M | (m) | (m) |
| 2012-03-31 | $422.00M | (m) | (m) |
| 2011-12-31 | $622.00M | (m) | (m) |
| 2011-09-30 | $853.50M | (m) | (m) |
| 2011-06-30 | $564.50M | (m) | (m) |
| 2011-03-31 | $564.50M | (m) | (m) |
| 2010-12-31 | $425.50M | (m) | (m) |
| 2010-09-30 | $111.10M | (m) | (m) |
| 2010-06-30 | $111.10M | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) |
| 2009-12-31 | $0.00 | (m) | (m) |
| 2009-09-30 | (m) | (m) | (m) |
| 2008-12-31 | $1.00B | (m) | (m) |
| 2008-09-30 | (m) | (m) | (m) |
| 2007-12-31 | $0.00 | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |